Sunday 5 January 2014

Study affirms safety of HPV4 vaccine for adolescents and young women in routine clinical care

Study affirms safety of HPV4 vaccine for adolescents and young women in routine clinical care

A study of almost 200,000 young females who received the quadrivalent human papilloma virus vaccine found that immunization was associated only with same-day syncope and skin infections in the two weeks after vaccination. These findings support the general safety of routine vaccination with HPV4 in a clinical care setting to prevent cervical and other genital and reproductive cancers. read more..

Mobile Application-Skincare-Women-Ioma

IOMA launches new skincare mobile app for women

Always closer to women and forever listening to their needs, IOMA launches a mobile application to help women better know their skin and help fulfill all their beauty desires. read more..

Free Skin Cancer Screenings-Human Neutrophil Peptide-Antimicrobial Peptides-Immune System Cells

Chicago-area dermatologists to offer free skin cancer screenings

Chicago-area dermatologists will offer free skin cancer screenings to sun worshipers at one of the city's most popular beach this summer. The screenings will take place from 10 a.m. - 4 p.m. on Saturday, Aug. 4, and Sunday, Aug. 5, at North Avenue Beach. read more..


Human neutrophil peptide 1 effectively prevents HIV entry into cells in multiple ways

Human defensins, aptly named antimicrobial peptides, are made in immune system cells and epithelial cells (such as skin cells and cells that line the gut). One of these peptides, human neutrophil peptide 1, under certain circumstances hinders HIV infection, but exactly how it works remains unclear. read more..